Tempus Ai Inc (TEM)

Nov 16, 2024

Short Interest in Tempus AI, Inc. (NASDAQ:TEM) Rises By 19.2% - MarketBeat

Nov 16, 2024

Nov 15, 2024

Tempus AI downgraded to hold by Stifel, valuation cited - MSN

Nov 15, 2024

Nov 15, 2024

Behind the Scenes of Tempus AI's Latest Options Trends - Benzinga

Nov 15, 2024

Nov 15, 2024

Sumitomo Mitsui Trust Group Inc. Buys 1,145,698 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat

Nov 15, 2024

Nov 14, 2024

AI Health Care Co. Can't Sink Ex-Worker's Sex Bias Claims - Law360

Nov 14, 2024

Nov 14, 2024

U.S. Indexes Dropped Thursday; Tempus AI Took Biggest Hit - Barron's

Nov 14, 2024

Nov 13, 2024

Sigma Planning Corp Acquires Shares of 23,369 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat

Nov 13, 2024

Nov 12, 2024

Piper Sandler raises Tempus AI stock target by 75%, keeps Neutral rating after earnings - Investing.com

Nov 12, 2024

Nov 12, 2024

Tempus AI: Pioneering the Future of Precision Medicine Through AI-Driven Innovation (TEM) - Seeking Alpha

Nov 12, 2024

Nov 12, 2024

U.S. Indexes Declined Tuesday; Tempus AI Fell Furthest - Barron's

Nov 12, 2024

Nov 12, 2024

Tempus AI's (TEM) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat

Nov 12, 2024

Nov 12, 2024

Tempus AI (NASDAQ:TEM) Sets New 12-Month HighHere's What Happened - MarketBeat

Nov 12, 2024

Nov 12, 2024

Tempus Partners with Flatiron Health, Brings Genomic Testing to 800+ Cancer Centers | TEM Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Stifel cuts Tempus AI stock to Hold, lifts PT on Ambry Genetics deal - Investing.com Australia

Nov 12, 2024

Nov 12, 2024

Tempus AI stock receives notable PT boost from $40 to $70 at Piper Sandler - Investing.com India

Nov 12, 2024

Nov 11, 2024

Tempus AI (NASDAQ:TEM) Shares Gap DownHere's Why - MarketBeat

Nov 11, 2024

Nov 11, 2024

Tempus Study: Combined RNA-DNA Testing Boosts Lung Cancer Detection by 15.3% | TEM Stock News - StockTitan

Nov 11, 2024

Nov 11, 2024

Tempus AI (NASDAQ:TEM) Cut to "Hold" at Stifel Nicolaus - MarketBeat

Nov 11, 2024

Nov 11, 2024

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - MSN

Nov 11, 2024

Nov 11, 2024

Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 11, 2024

Nov 11, 2024

Tempus AI Clears Technical Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily

Nov 11, 2024

Nov 10, 2024

Tempus AI to Buy Ambry Genetics for $600M - Orange County Business Journal

Nov 10, 2024

Nov 08, 2024

Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting - 01Net

Nov 08, 2024

Nov 08, 2024

ARK Investment Management LLC Raises Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat

Nov 08, 2024

Nov 08, 2024

Tempus AI Unveils Breakthrough Cancer Treatment Algorithm, Cost-Saving Study at SITC 2024 | TEM Stock News - StockTitan

Nov 08, 2024

Nov 07, 2024

Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56 - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test - 01Net

Nov 07, 2024

Nov 07, 2024

10 AI News You Shouldn’t Miss - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Exciting Growth Potential Ahead for Tempus AI (TEM) - Insider Monkey

Nov 07, 2024

Nov 07, 2024

Tempus Launches Breakthrough Cancer Immunotherapy Test After Major Clinical Success | TEM Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Tempus AI’s $600 Million Acquisition of Ambry Genetics - Global Legal Chronicle

Nov 06, 2024

Nov 06, 2024

Tempus AI to buy genetic testing company for $600M - MedTech Dive

Nov 06, 2024

Nov 05, 2024

Ambry Genetics Being Acquired by Tempus AI for $600M - Orange County Business Journal

Nov 05, 2024

Nov 05, 2024

Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Nov 05, 2024

Nov 05, 2024

Needham raises Tempus AI stock target on Q3 results, acquisition By Investing.com - Investing.com Australia

Nov 05, 2024

Nov 05, 2024

Needham raises Tempus AI stock target on Q3 results, acquisition - Investing.com India

Nov 05, 2024

Nov 05, 2024

Tempus: Q3 Earnings Snapshot - The Advocate

Nov 05, 2024

Nov 04, 2024

Tempus AI Inc Reports 33% Revenue Growth to $180.9 Million in Q3 2024 Amid Strategic Acquisition - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

Konica Minolta Sells Ambry Genetics to Tempus AI - TipRanks

Nov 04, 2024

Nov 04, 2024

Tempus AI Agrees to Acquire Ambry Genetics - MarketWatch

Nov 04, 2024

Nov 04, 2024

Tempus buying genetics lab company for $600 million - Crain's Chicago Business

Nov 04, 2024

Nov 04, 2024

Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics - Business Wire

Nov 04, 2024

Nov 03, 2024

Tempus to Report Third Quarter 2024 Financial Results on November 4 - 01Net

Nov 03, 2024

Nov 02, 2024

International Assets Investment Management LLC Buys 70,700 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat

Nov 02, 2024

Nov 01, 2024

Cathie Wood's ARK offloads Palantir and Tesla stock, buys Tempus and Twist - Investing.com

Nov 01, 2024

Nov 01, 2024

Tempus AI Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN

Nov 01, 2024